These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23540678)

  • 1. Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats.
    Liu Y; Richardson J; Tran T; Al-Muhtasib N; Xie T; Yenugonda VM; Sexton HG; Rezvani AH; Levin ED; Sahibzada N; Kellar KJ; Brown ML; Xiao Y; Paige M
    J Med Chem; 2013 Apr; 56(7):3000-11. PubMed ID: 23540678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A.
    Liu Y; Paige M; Olson TT; Al-Muhtasib N; Xie T; Hou S; White MP; Cordova A; Guo JL; Kellar KJ; Xiao Y; Brown ML
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2954-6. PubMed ID: 24844195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.
    Liu J; Eaton JB; Caldarone B; Lukas RJ; Kozikowski AP
    J Med Chem; 2010 Oct; 53(19):6973-85. PubMed ID: 20822184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
    Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
    Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, on body temperature regulation in mice and rats.
    Rezvani AH; Timofeeva O; Sexton HG; DeCuir D; Xiao Y; Gordon CJ; Kellar KJ; Levin ED
    Eur J Pharmacol; 2012 May; 682(1-3):110-7. PubMed ID: 22387853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
    Sharples CG; Karig G; Simpson GL; Spencer JA; Wright E; Millar NS; Wonnacott S; Gallagher T
    J Med Chem; 2002 Jul; 45(15):3235-45. PubMed ID: 12109907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats.
    Levin ED; Rezvani AH; Wells C; Slade S; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ
    Eur J Pharmacol; 2019 Feb; 845():1-7. PubMed ID: 30529197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
    Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
    Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in rats.
    Rezvani AH; Wells C; Slade S; Xiao Y; Kellar KJ; Levin ED
    Pharmacol Biochem Behav; 2019 Apr; 179():109-112. PubMed ID: 30794849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
    Kamens HM; Andersen J; Picciotto MR
    Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption.
    Touchette JC; Maertens JJ; Mason MM; O'Rourke KY; Lee AM
    Neuropharmacology; 2018 May; 133():63-74. PubMed ID: 29355641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
    Sotomayor-Zárate R; Gysling K; Busto UE; Cassels BK; Tampier L; Quintanilla ME
    Psychopharmacology (Berl); 2013 May; 227(2):287-98. PubMed ID: 23344555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.
    Rezvani AH; Cauley M; Sexton H; Xiao Y; Brown ML; Paige MA; McDowell BE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2011 Jun; 215(4):621-30. PubMed ID: 21274704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.
    Chatterjee S; Steensland P; Simms JA; Holgate J; Coe JW; Hurst RS; Shaffer CL; Lowe J; Rollema H; Bartlett SE
    Neuropsychopharmacology; 2011 Feb; 36(3):603-15. PubMed ID: 21048701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.